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Abstract
This paper presents an approach to the evaluation and validation of mass spectrometry data for
construction of an ‘early warning’ diagnostic procedure. We describe implementation of a designed
experiment and place emphasis on the consistent and correct use of validation based evaluation
- which is a key requirement to achieve unbiased assessment of the ability of mass spectrometry
data for diagnosis in this setting. Strict adherence to validation as a scientific principle will however
typically imply that the analyst must make choices. Like all choices in statistical analysis, validation
comes at a cost! We present a detailed and extensive discussion of the issues involved and propose
that much greater emphasis and requirement for validation would enter clinical proteomic science.
Keywords. Clinical proteomics, mass spectrometry, spectroscopy, classification, double cross-validation,
statistical design, diagnosis, pattern recognition.
1 Introduction
There currently is much interest in application of mass spectrometry for the construction of new diag-
nostic proteomic approaches for the early detection of disease. This is particularly the case in situations
where no reliable diagnostic tools have yet been developed.
Generally, in diagnostic research, we may be interested in two key problems or objectives. The
first and foremost of these is to ascertain whether there is any information in the data (in our case
mass spectra) to allow future cases to be identified with a high degree of reliability. The second is
the identification of the separating information (in this case proteomic markers) itself. At this stage,
some of our readers may be puzzled, as naturally, the ability to do the first would imply the presence
of prognostic (marker) information. From a purely statistical methodological point of view however,
the two problems are subtly different and pose different demands on the analysis. This is because a
proper answer to the first research question requires rigorous emphasis on fully validated estimation of
diagnostic performance. The second objective on the other hand poses a feature extraction or definition
problem and hence, by its very nature, may easily cause the analyst to introduce so-called data ‘tuning’
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reason also, all explicit references to mass/charge ranges or peaks/peptides identified has had to be removed from the
presentation, while the refereeing process continues. The authors would however like to include this information in any
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and optimization steps. This can arise through the need or desire to employ some form of data cleaning,
data preprocessing steps, use of algorithmic optimization techniques based on the complete observed
data and other similar interventions with the data. Hence, a conflict may arise and the analyst should
carefully weigh the options and consider the objectives to ensure that the primary research question can
be answered. In particular, if the first objective is of interest, then special care must be taken to strictly
avoid introducing any optimization steps which could result in optimistically biased assessment of the
diagnostic ability of the technology, unless some form of validation can be introduced to ‘counteract’
and assess the effects. Irrespective of these considerations, both research questions require carefully
designed experimentation to ensure validity of any study results.
In this paper, we discuss the problem of ascertaining the viability of using mass spectroscopic analysis
of serum samples for the construction of a diagnostic test for colorectal cancer at an early stage of the
research effort. In other words, we describe - in essence - a feasibility study. A crucial objective of such
studies is to provide information which allows us to make decisions as to the continuation of the research
effort (which may involve experiments of much greater cost and complexity in comparison to the first-
stage evaluation). Hence, it is essential to get a fully validated and unbiased assessment of predictive
error rates and thus the primary research objective is clearly concerned with the first research question
discussed above.
We will now first discuss some additional complicating special issues which are a concern with mass
spectrometry proteomics as well as a brief discussion of the data, prior to a summary of our objectives
and outline description of the remainder of the paper.
1.1 Mass spectrometry proteomics, sample size and clinical science
A key problem in many proteomic studies - but similar problems arise in many other similar settings
(e.g.: microarray diagnostics, chemometric discriminant studies) - is the difficulty to collect a sufficient
number of samples. In oncology applications this will tend to happen, simply because the cancer of
interest may be (relatively) rare. Our example is again a typical one, as although colorectal cancer
is one of the most common human malignancies, the number of patients any hospital may expect to
encounter on a yearly basis will be limited. On the other hand, clinicians and biomedical researchers
who wish to explore application of proteomic mass spectrometry technology for the construction of new
diagnostic procedures, will be interested first to get an indication of whether there is information in the
spectra to allow groups to be separated and what the likely error rates of misclassification will be. Both
these reasons conspire to cause many proteomic studies to be of small sample size initially.
While small sample size causes problems of precision of model calibration in the first instance,
it causes special problems in the proteomics setting because of two complicating reasons. First is
the complexity of the mass spectrometry signal which can consist of hundreds of possibly overlayed
peaks, which are typically stored on a discretised predefined fine grid of bins. As a consequence and
in combination with small sample size, this provides the ideal setting for so-called ‘data-dredging’
exercises which easily generate unsubstantiated claims. The second problem is that across institutions
and research groups we can expect many such attempts being undertaken to explore application of
proteomic mass spectrometry for diagnosis. For all these reasons, there is an urgent need for fully
validated methods of discriminatory assessment of proteomic patterns which are sufficiently critical and
conservative and give unbiased estimates of error rate in small sample size situations.
1.2 Mass spectrometry data
The experiment and data discussed and analyses in this paper are derived from a MALDI-TOF (Ma-
trix Assisted Laser Desorption Ionisation Time-Of-Flight) mass spectrometer (specifically a Ultraflex
TOF/TOF instrument, Bruker Daltonics, equipped with a SCOUT ion source which was operated in
linear mode). The spectrometer produces a sequence of intensity readings for each sample on an ordered
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set of contiguous bins in the m/z range from UUU to VVV Dalton. Bin sizes (length) of the unprocessed
spectra gradually increase with increasing m/z values, ranging from 0.07 Dalton at the lower end of the
mass/charge scale up to 0.24 Dalton at the upper end of the scale.
We now summarize our objectives with this paper, which are to...
...explain and propose full double cross-validation based methodology for assessment of diagnostic
potential.
...explain the limitations which an analyst and researcher must endure and empose on themselves
in order to maintain the benefits from a fully validatory approach.
...propose design suitable for first-stage evaluation of diagnostic potential and which can also
support double cross-validation.
...to describe application to the colon cancer mass spectral data.
...to propose that validation should be given much greater prominence in wider scientific diagnostic
research and that double cross-validation can play an important role to achieve this in the first
stages of evaluating a new methodology for diagnostic purposes.
We will discuss design first, followed by a description of the discriminant method and a double
cross-validatory approach to joint estimation and validation of the allocation rule, which allows for
validated error rate evaluation. We pay special attention to the implied consequences for both the
design and analysis strategy if we are to avoid bias as a consequence of optimization. As we have
explained, this will apply particularly to preprocessing steps which should be carefully considered to
prevent such problems from affecting the credibility of the first evaluation of the discriminatory potential
of the data. Put simply: any assessment of such potential must reflect the data, not the abilities of the
analyst to - perhaps inadvertently - artificially induce it. In practice, this implies that an analyst must
make choices - perhaps even sacrifices - and we describe the issues involved. Subsequent to description
of the methodological approach, we discuss application to the colon cancer data and present a post
hoc exploratory data analysis to interpretation of the results. While we will focus on our example to
structure the discussion, the issues apply quite generally to similar problems in proteomics and many
other related problems in bioinformatics, chemometrics, statistical prediction and beyond. We will
assume that the reader has some knowledge of standard leave-one-out cross-validation.
2 Design and validation
2.1 Design
A key and characteristic problem of proteomic mass spectrometry design is the need to cope with
the presence of what we may loosely refer to as so-called ‘batch effects’. Examples are plate-to-plate
variability, day-to-day variation and so on. The presence of such effects is in reality unavoidable. A naive
response to the problem could be to construct designs and experiments, which avoid or eliminate the
presence of such effects (assuming that we can anticipate them properly). However, this will typically
imply sample size restrictions on the designs which are undesirable. A better approach is - rather than
try to eliminate them from the design - to account and accommodate for these effects in such a way
that they do not lead to erroneous or artificially induced between-group separation. In addition, this
makes experimentation more realistic also as any ‘real-life’ application of the methodology would also
have to cope with the presence of such effects.
The problem is a standard example on application of principles of statistical design which have been
well described in many classical textbooks and have now been known for almost a century. The typical
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first step in applying this knowledge is to first try and identify - or at least think about - what the
potentially important batch effects might be in advance. In our case plate variation, but at least also
day-to-day variation - such that we may think of each plate-by-day combination as a batch - commonly
referred to as a ‘block’ in standard statistical terminology. We may then randomly distribute the
available samples from each group (colon cancer and controls) across the blocks such that proportions
are (as near as) equal within and across blocks for each group. For colon cancer, we randomized samples
to plates in such a manner that the distribution of disease stadia was in approximately equal proportions
across plates as well. The position on the plates of samples allocated to each plate was also randomized.
Each plate was then assigned to a distinct day, which completes the design. Table 1 summarizes the
design as executed on the first week, which provides us with mass spectra on 63 colon cancer patients
and 50 healthy controls .
Table 1: Design as executed on the first week. A replicate of the entire experiment was run on
the subsequent week using plate duplicates. ‘Stage’ refers to the distribution of cases across the four
respective disease stages.
Group Plates Total
1 2 3
Controls 17 17 16 50
Cases 22 22 19 63
Stage 1 2 3 4 1 2 3 4 1 2 3 4
Cases 4 10 4 4 4 10 4 4 3 8 4 4
In our case, it was decided to carry out the experiment in a single week using three plates only, each
of which was assigned to a consecutive day in the middle of the week - Tuesday to Thursday. Generally
speaking however, it is often wise to try and increase the number of blocks rather than seek to reduce
it when batch effects are at issue - which is the typical, but actually rather naive first response of the
‘uninitiated’ in these circumstances. For example, we could have spread the experiment across several
weeks and use several plates per day with the same design configuration across weeks, which would allow
for a separate analysis to study and disentangle batch-to-batch variability (besides the analysis of the
main research question). More importantly, this tends to make the design more robust as the sample
material gets spread across a larger number of blocks which implies reduced loss of sample material
in case problems arise during the experiment with any specific block (see further on for an example).
An advantage of running the experiment in a single week is that it may be more easy to maintain
the study protocol across the study, which can be a particular issue if the research facility carrying
out the measurement has to provide for several customers using the same facilities. Good laboratory
management makes the latter argument less credible however.
The above described design is also referred to as randomized block design in the statistical literature
and will ensure that the batch effects - if they materialize - will not induce an artificial between-group
effect or separation. We refer the reader to the statistical literature on design of experiments for further
discussion and details of the issues involved, as well as many other examples of these basic design
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principles ((Cox 2000), (Box 1978), (Neter 1996), (Fisher 1935) among others).
2.2 Validation
We can exploit design to augment cross-validatory analysis. This is because while sample sizes may be
small (i.e. it is difficult to get new independent samples), the amount of sample material available for
each sample may be more abundant. This allows the introduction of so-called replicate samples into the
design.
As the samples are pre-arranged on rectangular plates, a second ‘copy’ of any plate can be made
provided sufficient sample material is available from each sample. (In our case, sufficient sample material
was available for a second copy only). Thus, we can duplicate the entire design from the first week and
remeasure the replicate plates through the same design on the second subsequent week, using new
sample material from each sample (but of course not new samples themselves). With this approach, we
thus generally have available from each ith sample an observation x1i = (x
1
i1, . . . , x
1
ip) of the associated
recorded mass spectrum in the first week, where the vector elements refer to the measured mass/charge
intensities on a predefined and ordered grid of mass/charges of dimensionality p. In addition, we have
for each sample a duplicate measurement x2i = (x
2
i1, . . . , x
2
ip) obtained from the corresponding replicate
on the corresponding plate measured on the same day one week later. We may denote the associated
class label from each ith observation as c(i) which takes value in the set of group indicators {1, . . . , G},
where G is the number of groups. [Note we will drop use of the suffixes 1,2 when the context makes
clear to which week the data relates.]
Unfortunately, the replicate measurements from the third plate are unavailable due to a technical
malfunction which occurred on the last day of the second week. As a consequence we only have available
the 78 replicates from the first 2 plates in week 2 for further analysis.
3 Integrated calibration and validation for classification by dou-
ble cross-validation
Given the need to provide fully validated error rates and to keep the problem of overfitting under
control, we will restrict attention to double cross-validated linear discrimination for joint calibration
and validation (Stone 1974). We explain shrinkage-based estimation and the need for it in linear
discrimination first. Then we explain the double cross-validatory implementation.
3.1 Linear classification and shrinkage estimation methodology
We base classification on Fisher linear discrimination (Fisher 1936), which is one of the oldest statistical
allocation methods and certainly the most widely used and successful approach to statistical classification
and pattern recognition to this day. It has been derived and may be justified based on a variety
of principles of inference, such as maximization of the between-group separation relative to within-
group error in the two-group case (Fisher’s original argument) or the likelihood principle for normally
distributed within-group populations, among others. The methodology has been amply studied and has
been established as an extremely reliable and robust form of classification and discriminant analysis - for
example, even when assumptions to pool covariance matrices are not fully met. It is also important to
note that Fisher discrimination does not require an assumption of within-group normal dispersion. We
must refer to the voluminous literature for further details on the method (Hastie 2001), (Seber 1984),
(McLachlan 1992), (Ripley 1996) which is well established in the applied sciences, such as biology
and medicine. Hastie et al. (2001) contains an up-to-date account of many new applications which
demonstrate the continuing success of the approach.
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Fisher linear discriminant allocation may be defined as assigning a new observation with feature
vector x to the group for which the distance measure
Dg(x) = (x− µg)Σ−1(x− µg)T
is minimal, where g denotes the group indicator with g ∈ {1, . . . , G}, µg the population means and Σ
the population within-group dispersion matrix which is assumed equal across groups. In practice, the
population means and dispersion matrix will be unknown and hence must be estimated from the data.
In a high-dimensional problem such as in mass spectrometry proteomics, this leaves us with a difficulty
in estimating the dispersion matrix as we will typically not be able to achieve a full rank estimate.
At the risk of some oversimplification of the discussion, there are basically two ways in which we
may remedy the problem so that the above methodology may again be applied. The first is through
the selection or construction of a set of features which is reduced in dimensionality, while capturing
most of the variability in the data. In essence, this is the approach which is currently applied in
most of the mass spectrometry proteomics literature (at the time of writing) through so-called ‘peak’
selection and construction algorithms, spectral alignment algorithms and other similar preprocessing
procedures, which are applied prior to subsequent further analysis to construct diagnostic rules, or
other prognostic models. Typical examples are found in papers by Baggerly, Yasui, Sauve, Morris
((Baggerly 2003),(Morris and Coombes et al. 2005),(Sauve 2004),(Yasui et al. 2003)), among others. It
is important that readers understand that we do not consider this approach to be fundamentally flawed
for mass spectrometry proteomic data. On the contrary, it is self evident that mass spectra consist
of mixtures of possibly overlaid intensity peaks corresponding to substances present in the analyte.
Thus, to try to elucidate this structure (first) is in principle of interest. Problems will however arise
when validation and unbiased assessment of error rates or any other measure of predictive performance
are crucial. This is because preprocessing may involve a high degree of optimization which is itself
data-driven. This applies particularly to problems of peak selection and definition, and certainly to
alignment.
For these reasons and because unbiased error rate estimation is crucial to our goals, we will pursue
the second option, which is to reduce the preprocessing steps to such an extent that they no longer
introduce any optimization which can no longer be validated. We then leave the dimensionality of the
data intact but introduce a regularized estimation of the dispersion matrix to cope with the singularity
of the sample dispersion matrix. This approach can be conservative and may well not provide the most
optimal classifier and error rate, but will at least not be optimistically biased.
We will explore two distinct forms of regularization, both of which may be expressed in terms of the
canonical decomposition of the ‘observed’ (or sample) pooled dispersion matrix S = QΛQT where Q
and Λ = diag(λ1, ..., λr) are the matrices of principal component weights (or loadings) and variances
respectively, with λ1 > ... > λr > 0 respectively (r is the rank of the pooled covariance matrix). We may
now re-estimate the within-group covariance matrix by only retaining the first 1 ≤ k ≤ r components
only, which gives an estimate
S(k) = Q(k)Λ(k)Q
T
(k),
whereΛ(k) = diag(λ1, ..., λk) andQ(k) denotes the corresponding reduced matrix of component loadings.
The associated linear discriminant allocation rule hence assigns observations to the group for which the
smallest sample-based distance estimates
D̂g(x) = (x− xg)S−1(k)(x− xg)T
are observed, with xg the sample group means for g ∈ {1, ..., G}. In the two-group case, this is also
equivalent to least-squares regression analysis using the Moore-Penrose inverse of the pooled covariance
matrix when k = r (all components kept, also known as shortest least squares regression), or else
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(k < r) is equivalent to so-called shrunken least-squares regression ((Ripley 1996) or (Hand 1997) for
more details). An alternative is to employ a ridge regularization
S(γ) = Q[(1− γ)Λ+ γI]QT ,
where 0 < γ ≤ 1 is the ridge regularization or ‘tuning’ parameter, in which case the sample distance
measures are (x− xg)S−1(λ)(x − xg)T .
3.2 Double cross-validatory estimation and validation
Application of the above described classification approaches still requires choice of the tuning parameters
k or γ involved. As we are specifically interested in an evaluation of predictive performance of any
diagnostic allocation rule, it becomes crucial that any optimization - such as the choice of the tuning
parameters - does not take place on the same data used for validation. On the other hand, predictive
tuning is clearly highly desirable if diagnosis is of interest, so we would not wish to base the choice of
tuning parameters on the full calibration data itself (and thus effectively drop predictive tuning from the
analysis), but use a truly validatory choice instead. This implies we either set aside a so-called separate
‘tuning set’ from the available calibration data prior to validation of predictive performance itself or
appeal to some form of cross-validation. Good predictive optimization or tuning becomes particulary
important in a high-dimensional setting, such as proteomics, as it provides a crucial opportunity to
safeguard model choice against overfitting (in other words: over-interpreting the data). Meanwhile,
even if we were able to effectively choose good tuning parameters, the predictive performance (in our
case essentially the error rates) of any implied allocation rule should again be validated, which again
introduces a need for yet another set-aside validation set or cross-validation.
We may solve both problems by carrying out a so-called double-cross-validatory approach, which
avoids the need to introduce separate test (tuning) and validation sets. The method has been first
proposed and investigated by Stone (Stone 1974) and integrates predictive optimization and unbiased
validated error rate estimation in a single validatory procedure. While the principle of the methodology
is sound and well described, this procedure has until recently not been applied in practice due to the
considerable computational cost and (algebraic) complexity of the method. (See (Mertens 2003) for a
first full implementation in the related setting of discriminant allocation on microarray data.)
As with ordinary leave-one-out cross-validation, double cross-validation removes each individual
(sample) in turn from the data, after which the discriminant rule is fully recalibrated (and optimized for
prediction) on the leftover data and using the same procedure in each case. The resulting classification
rule is then applied to the left-out datum to obtain an unbiased allocation for this sample. This procedure
is then repeated across all individuals and for each person separately, after which misclassification rates
are calculated on the basis of the thus validated classifications. The double-validatory aspect results
from the fact that the discriminant rule constructed to classify each left-out datum is optimized through
a secondary cross-validatory evaluation within the first cross-validatory layer (i.e. full cross-validation
again on each ‘leftover’ set after removal of an observation). In this manner, we are able to integrate
predictive optimization and predictive unbiased validation in the same procedure, without loss of data
- which is a crucial requirement to get realistic estimates of error rate with high-dimensional data.
4 Application and evaluation
4.1 Preprocessing
Preprocessing is potentially hazardous as it may induce optimistic bias into the error-rate evaluation. On
the other hand, pre-processing can be beneficial and justified if it removes variation from the data which
does not relate to the group separation and might obscure an existing group separation. Put simply,
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preprocessing is allowed as long as the preprocessing steps undertaken for any sample are not based on
any borrowing of information or ‘learning’ on the basis of the other samples. In other words: it must
be ‘within-sample’ preprocessing. Note that this conflicts with some of the preprocessing procedures
which have been applied by other authors in the proteomics literature (e.g. Coombes, but also Baggerly
and Yasui). At this point, we will describe the preprocessing steps that were employed in our analysis.
We defer a detailed discussion of pre-processing and the specific potential problems and differences with
other authors to the discussion.
First, we calculated for each sample the average intensity within each bin across the four mass
spectra from the associated spots on the plate. Then, we aggregated contiguous bins on the m/z scale,
such that the new aggregated bin size spans approximately one Dalton at the left side of the spectrum
and gradually increases to a width of approximately 3 Dalton at the right hand side. For each of these
new aggregated bins, we calculated for each spectrum the associated aggregate intensity by summing
the intensities across the bins being aggregated. Subsequently, spectral baseline was then removed from
each of the thus aggregated spectra separately using an asymmetric least squares algorithm.
Suppose xbi = (xbi1 , . . . , xbip) denotes the ordered sequence of baseline corrected m/z intensity values
for the ith sample at this stage of preprocessing. We then correct the spectrum for the typical intensity
and variability across the spectrum by calculating the standardized values
xsbij =
xbij −median(xbi)
(q0.75(xbi)− q0.25(xbi))
,
where q0.25(xbi ) and q0.75(xbi )) denote the 25
th and 75th percentiles of the baseline corrected intensity
values for the ith sample. Some readers will note that these steps bear close resemblance to the prepro-
cessing procedure proposed by (Satten et al. 2004), although ours is a cruder version which does not
employ local estimates. The final preprocessing step is a log-transformation
xij = log(xsbij + α)− β
of each spectrum, where α and β are two real constants. We chose α = 100 and β = 4. The main
purpose of the log-transform is to ensure numerical stability of calculations.
The above preprocessing steps were applied for each sample and within each week separately, which
thus gives us the observations x1i and x
2
i from the first and second weeks. It is important to stress that
the preprocessing of the data of any ith sample does not involve use of any information based on the
remaining samples {k | k 6= i}, nor of the duplicate replicate measured spectrum of the same sample
on another week. This is a vital requirement to ensure the validity of any cross-validatory evaluation.
In addition, there are more general reasons to avoid any such processing in the classification/diagnosis
context at least, for reasons we will go in to more detail in the general discussion.
4.2 Double cross-validatory error rates
Using the above described preprocessed data, we may carry out a double- cross-validatory evaluation of
predictive performance of the classifiers we discussed. In the first instance, we restrict ourselves to the
data from the first week. Table 2 displays the estimated recognition rates and performance measures
from an analysis of the first week data (leftmost 3 columns). All of the estimates are based on double
cross-validation. We used the average of sensitivity (Se) and specificity (Sp) as our estimate of the
total recognition rate (T), which implies we assume prior class probabilities to equal 0.5. A threshold
of 0.5 was also used to assign observations on the basis of the a-posteriori class probabilities within the
cross-validatory calculations. B denotes the Brier distance which we define as
B =
√
1
n
∑
i
[1− p(c(i) | xi)]2,
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Figure 1: Mean spectra for each group separately, after preprocessing. We plot negative intensity value
for the control group (bottom mean spectrum).
where p(c(i) | xi) is the double cross-validated predicted a-posteriori class probability for the correct
class c(i) for each ith sample and n is the total sample size. Likewise, AUC is a double cross-validation
estimate of the area under the empirical ROC curve defined as
AUC =
1
n1n2
∑
i∈G1
∑
j∈G2
[I(p(1 | xi) > p(1 | xj)) + 0.5 ∗ I(p(1 | xi) = p(1 | xj))],
whereG1 andG2 refer to the sample index labels for samples from the first and second group respectively.
The rightmost three columns of the table refers to a repetition of this entire double cross-validatory
exercise, which replaces each sample feature vector x1i with the corresponding replicate measurement x
2
i
immediately prior to classification of that ith sample (i.e. replacing the feature vectors with the data
from week 2 in the outermost layer (only!) of the double cross-validatory calculation). Crucially and
importantly, construction of the corresponding discriminant rule for the classification of each such ith
sample in the internal ‘calibration’ layer of the double cross-validatory procedure does of course remain
based on the data from week 1. Note that as the replicate data from the third plate are not available,
these results are based on the double cross-validated predictions for the remaining 78 replicate samples
from week 2 only.
At first sight, the Moore Penrose implementation (top line of the table, both weeks one and two)
would seem to be the best performing and most consistent method. In week 1, Moore-Penrose, PCA-
selection (both using the Mahalanobis distance) and ridge estimation perform equally well, but there
seems to be an increase in error rate for week 2 for both the PCA-selection and ridge implementa-
tion. The Euclidean distance based implementations are worse in the evaluation on the first week, but
recognition rates are consistent across both weeks when compared to the other methods.
These results should be interpreted with some caution and require some explanation. First of
all, the ‘plain’ Moore-Penrose is leave-one-out only as it does not involve choice of shrinkage or data
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Table 2: Double cross-validated classification results for the colon cancer data. T is the total recognition
rate. Se and Sp are sensitivity and specificity respectively. B is the Brier distance and AUC is the
estimated area under the ROC curve.
Method First week Second week
T (Se,Sp) B AUC T (Se,Sp) B AUC
Moore-Penrose S(r) 92.6 (95.2,90.0) 0.0905 97.6 94.4 (91.7,97.1) 0.0885 97.4
PCA-selection S(k) 92.6 (95.2,90.0) 0.0786 97.3 88.8 (80.6,97.1) 0.0935 96.8
Moore-Penrose Euclidean S(r) Λ(r) = I(r) 89.4 (88.9,90.0) 0.179 96.0 87.2 (86.1,88.2) 0.190 97.0
PCA-selection Euclidisch S(k) Λ(k) = I(k) 88.7 (87.3,90.0) 0.184 96.0 90.0 (88.9,91.2) 0.192 97.0
Ridge S(γ) 92.0 (95.2,88.0) 0.0909 98.4 95.8 (91.7,100.0) 0.0918 97.9
reduction parameter (k or λ). The deterioration of the PCA-selection implementations is partly due
to the uncertainty in estimating the shrinkage terms or choice which is introduced by the double-
cross-validatory estimation. For the ridge implementation, performance is comparable to that from
Moore-Penrose in week 1, which is not surprising since the chosen ridge shrinkage parameter λ < 0.0001
for most observations. The effects of uncertainty in the determination of the shrinkage term becomes
particularly apparent for PCA-selection using Mahalanobis distance (second line in the table) in week
2.
The two Euclidean distance based implementations on the other hand seem more consistent across
both weeks. The reason is that component selection is much more stringent for these two implemen-
tations, which selects only the first 2 components for nearly all observations (with exception of two
observations out of 113 for which only the first principal component is retained). This explains the
reduced performance but also the greater consistency of the classification results. It is precisely because
of this reason that these results (from the Euclidean based implementations) are more credible and may
well turn out to be more repeatable if the classifier were applied in the future to data from a new repeat
experiment. For comparison, component selection in the Mahalanobis distance based PCA implemen-
tation is much less stringent and selects (k = 23 for 53 observations, k = 28 for 28 observations and
the remainder of the samples uses even more components). There is thus some evidence of insufficient
shrinkage for this method, and similarly for the ridge implementation.
4.3 Investigating bias: a permutation exercise
We have proposed double cross-validatory integrated estimation and assessment of statistical diagnostic
rules on the basis of the argument that it should protect against optimistically biased evaluations. We
may check this property by ‘removing’ the class labels c(i) from the samples i ∈ {1, . . . , n}, randomly
permute and then reassign them to the samples. We then carry out the double cross-validatory procedure
again for any of our classification methods. Repeating this procedure several times will give an indication
of the biases involved, as the typical recognition rate - for example - should equal 50% across a large
number of permutations for an unbiased method.
Table 3 shows results from such an exercise for the pca-selection based algorithm across more than
600 such permutations. The results, both for misclassification rate and area under the (ROC) curve
clearly demonstrate the method to be free from bias as we find median rates and areas of 50% exactly.
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Table 3: Permutation-based evaluation of double cross-validatory calculations for linear discrimination
using principal component selection. DBCV refers to the actual double cross-validatory results (see
table 2). q2.5 and q97.5 are the 2.5 and 97.5 percentiles. B is the Brier distance and AUC is the
estimated area under the ROC curve.
permutation results
measure DBCV median q2.5 q97.5
misclassification rate 7.4 50.0 36.3 72.7
AUC 97.3 49.4 24.8 64.2
B 0.0786 0.324 0.200 0.446
On the other hand, table 3 also includes 95% confidence intervals for the permutation-based per-
formance measures. These give an indication of the variability which can be expected with purely
random data and can be compared with the actually observed double-cross-validation results in our
study (second column of the table). Clearly, the distance between the validated measures actually ob-
served and even the extreme bounds of the random permutation confidence intervals is considerable,
which demonstrates the presence of discriminating information in the mass spectra.
4.4 Data reduction and post-hoc exploratory analysis
It is a key feature of our analysis that it places strong emphasis on estimating fully validated error rates
and all steps in the analysis are geared towards that end. This choice forces a discipline upon us not
to (re-) induce bias via preprocessing, which specifically precludes any form of either peak ‘selection’ or
‘definition’. Therefore, while the analysis is strong on establishing such unbiased error rates (and other
such measures of predictive performance) and the presence of ‘predicting’ or ‘discriminating’ information,
the analysis is necessarily not equally outspoken in telling us where this information is to be found in
the spectra. Thus, at this point, we may have convinced clinicians of the wisdom of randomized block
design and (double cross-) validatory analysis, but still leave an uneasy feeling as the approach would
appear not to be very transparent as to ‘how’ the classifier assigns observations. We should wish to
get an indication of what the markers are which drive the classification - or at least an assurance that
the classifier is not classifying in the noise region of the spectra. Of course, it would be wrong to label
this issue as a deficiency of the methodological approach. Rather, it is a necessary consequence of strict
adherence to proper protocols for evaluating predictive ability in a high dimension/small sample size
situation.
The dilemma is however not as acute or serious as would appear at first sight. Indeed, there is
nothing stopping us from carrying out a post-hoc exploratory analysis of both the results and data
(after the validatory calculation). This may include repeating the analysis after (possibly) some more
elaborate preprocessing which does not have to abide by the limitations of full validation. We describe
two post-hoc exploratory analyses. The first is based on a very ad hoc algorithmic approach through
pre-selection of a small set of adjacent bins which together account for most of the variation in the
spectra.. The second explores the linear discriminant weights from a post-hoc fit on the full data.
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4.4.1 Data reduction
Initialize I = {1, . . . , p} as the ordered set of bin indices and V = {v1, . . . , vp} the associated set of
variances for all p bins in the preprocessed spectra and across all n samples, such that vj =
∑
i[(xij −
xj)
2]/(n − 1), where xj =
∑
xij/n is the sample mean and j is the bin index number. Calculate the
constant vref = q0.95(V ) as the 95% percentile of all p bin variances. Now initialize the bin selection
set B as the set containing the bin indicator j for which the maximum variance vj is observed in the
set V . Initialize the set of intensity readings Xs = {x[j] | j ∈ B} corresponding to the set B, where
x[j] = (x1j , . . . , xnj )
T . We write m = (m1, . . . ,mn)
T as the set of means mi = mean({xij | j ∈ B}),
i : 1, . . . , n. Define cor(a,b) to be the coefficient of correlation between two vectors a and b.
Now run the following algorithm.
{Start of outer loop}
{Start of inner loop}
Set k=1, I = I − {j} and V = V − {vj}
Now iterate the following procedure until termination.
Calculate ρlower = cor(mi,x[j−k]) and ρupper = cor(mi,x[j+k])
If ρlower > 0.9 and ρupper > 0.9 then
1. Add j − k and j + k to the bin selection set: B = {j − k} ∪B ∪ {j + k}.
2. Update the means mi,i : 1, . . . , n.
3. Remove indices j − k and j + k from the index set I, such that I = I − {j − k, j + k}.
Similarly update V = V − {vj−k, vj+k}
4. set k=k+1
Else
k=k-1
End iteration.
Now select the bin index j for which vj = max(V ).
If vj > vref then
Update the index set B = B + {j} and likewise Xs and m.
Go to {Start of inner loop}
Else End algorithm.
The algorithm identifies a set of ‘clusters’ of bins. It is important to note there is no assumption on
either shape of the signal or of monotonicity involved (a single cluster may span mixture of underlying
peaks). Running this algorithm on the data from the first week finds the set of indices B that corresponds
to the bins which account for most of the variation in the data. Applying this to our data results in a
subset of 330 bins (in 32 bin clusters - but it is possible that we visit the same contiguous region of bins
several times). Repeating the entire double cross-validatory procedure using the principal component
selection shrinkage procedure on this reduced set yields recognition rates as described in table 4, which
are not inconsistent with those from the full double cross-validatory evaluation shown in table 2. Hence,
we may conclude that classification is not in the noise region of the spectra.
4.4.2 Post-hoc data exploration
The second aspect which is of interest is a post-hoc exploration of the (linear) discriminant coefficients
β = (β1, β2, ..., βp)
T = S−1(k)(x1 − x2)T [see (Seber 1984) or (Hand 1997)], where x1 and x2 are the two
sample group means (for cases and controls). An appropriate and convenient way to summarize and
present the information contained in these coefficients is via the associated correlations of the measured
intensities for each jth bin with the class indicator, which are easily calculated as ρj = sxjβj/sg, for
j = 1, ..., p where sxj =
√
vj is the standard deviation at the j
th bin and sg the standard deviation of class
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Table 4: Results from re-running double cross-validatory calculations after bin-selection for the colon
cancer data (week 1 data only). T is the total recognition rate. Se and Sp are sensitivity and specificity
respectively. B is the Brier distance and AUC is the estimated area under the ROC curve.
Method T (Se,Sp) B AUC
PCA-selection S(k) 90.0 (92.1,88.0) 0.115 96.4
PCA-selection Euclidisch S(k) Λ(k) = I(k) 89.0 (92.1,86.0) 0.173 95.4
indicators. We will base this investigation on the linear discriminant fit using the Euclidean distance
on the first two principal components (use S(k), with k = 2 and Λ(k) = I(k)), as the double validatory
assessment of this classifier clearly identifies the first 2 components as containing the discriminatory
information.
At this point, we can carry out the analysis starting from a linear discriminant fit based on the
full data. Alternatively, we may equally well base the evaluation on a recomputation of the linear
discriminant fit on the reduced data described in previous subsection (in both cases we use the data
from the first week). Figure 2 (middle section) shows a plot of the correlation coefficients, subsequent
to data reduction (previously described selection of 330 bins, but of course now using all 113 samples
from the first week). We only show results within the m/z region between AAA and BBB Dalton, as the
correlations are effectively zero in the remainder of the m/z range. Evidently, this immediately implies
that the separating information is to be found within the AAA to BBB m/z range. We note that the
picture shown is virtually indistinguishable by eye from that which results from an analysis of the full
data (not shown to save space). The reason for this is that the data reduction restricts attention to
the dominant sources of variation, which is not very different from what is achieved through principal
component reduction. Immediately above the correlation coefficients graph, figure 2 displays the first
two principal components (vertically offset and rescaled to aid visual interpretation) and again based on
the reduced data. In this case, the distinct bin subsets selected by the previous data reduction step are
clearly visible in the two components, and display the characteristic ‘peaks’ we would expect to identify.
Disjoint neighboring bin sets are connected with straight lines. The thus calculated components are a
close approximation to those which would result from an analysis of the full data, as we should expect
(results not shown). As for the correlation coefficients, any conclusions are therefore identical whether
we use the reduced data or not, although the data reduction step perhaps makes the component plot
easier to ‘read’. At the bottom of the graph we give the mean spectrum again for each group separately
and from the original data within the m/z range of interest, as shown in figure 1 also, along the complete
m/z range.
From this graphical analysis, it is immediately obvious how the linear discriminant correlation coef-
ficients identify two major discriminating contributions, the first of which is centered at XXX Dalton
and the second at YYY Dalton. Furthermore, the correlations have opposite signs at these locations,
which would indicate that the discriminating information can be summarized through a contrast effect
between corresponding measured intensities in the spectra. An investigation of the principal compo-
nents plots above, learns that the contribution at XXX Dalton is primarily accounted for by the first
component, which also already contains the contrast with intensities recorded at YYY Dalton. This
contrast is then further amplified by the second component which identifies a second orthogonal source
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Figure 2: Discriminant correlation coefficients ρj = sxjβj/sg of observed intensity values with the class
indicators in the m/z range from AAA up to BBB Dalton. We have plotted the first two principal
components above these correlations for visual comparison and interpretation. Below the correlations,
we plot mean spectra per group (i.e., the vectors x1 and x2, as in figure 1). The y-axis is only relevant
to the correlation coefficient, while we have vertically offset and rescaled both components and mean
spectra to aid visual comparison across the m/z range.
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of variation relative to the first component, centered predominately at the already identified peak at
YYY Dalton. Note how each component identifies several other smaller contributions, which could also
be of interest for further investigation. Comparing these graphs with the within-group mean spectra,
the resemblance with the principal components plots at the top of the figure are striking and would
suggest that the first component may be primarily explained through variation within the control group
at XXX Dalton. Likewise, the second component accounts for a substantial intensity peak at Dalton
within the colon cancer group.
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Figure 3: Scatter plots distinguishing cases (o) from controls (+). On the left we plot the second versus
the first principal component. The right plot shows intensity values at YYY m/z versus those at XXX
m/z.
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Figure 4: Plot of the contrasts (differences) between intensities at XXX m/z and m/z across all obser-
vations, using distinct plotting symbols for each group: cases (o) and controls (+).
To investigate this further, figure 3 provides scatter plots of cases and controls versus the first 2
components (left plot) and between intensities at XXX and YYY Dalton respectively (right plot). The
resemblance between both graphs is striking as the right plot can be obtained (virtually) after clockwise
rotation of the left plot. As we can see, increases in intensity at XXX Dalton separates controls from
cases. Similarly, an increase in intensity at YYY Dalton separates cases from controls. The same
interpretation applies to the principal components scatter plot, which confirms our interpretation of
the data in figure 2. Figure 4 provides a concise summary graphical illustration of the results. We
calculate the contrast (difference) for all 113 individuals participating in the study between the measured
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intensities at XXX and YYY Dalton and display the differences in a dotplot using distinct plotting
symbols for cases and controls respectively, which demonstrates the separation between both groups.
For further discussion of the clinical background, study rationale, setup, execution and interpretation
of results from a substantive clinical perspective, we refer to (de Noo et al. 2005) and subsequent papers
from these authors.
5 Discussion
5.1 Current statistical ‘proteomic’ practice
Most analyses and papers on use of mass spectrometry proteomics for diagnosis, prognosis and prediction
of treatment response are currently employing a so-called two-stage approach, of which the first step
consists of (extensive) pre-processing procedures and the second application of some classification or
more general ‘prediction’ algorithm (e.g. (Baggerly 2003) (Yasui 2003) among others). While this
approach may at times appear fast on the way to establishing a ‘proteomic dogma’, there is actually no
agreement as to precisely what pre-processing steps should be applied and how these may find their place
in a coherent analysis strategy. Thus, while there is much enthusiasm in ad hoc algorithm-writing, the
methods proposed (and perhaps also results) may be conflicting. Meanwhile, the dangers of such pre-
processing are little recognized, particularly with respect to the potential effect on error rate calculation.
This may not matter too much if the objective of the analysis is purely data-exploration. However, if
the objective is to calculate an estimate of prediction error or the identification of markers that allow
us to discriminate between or prognosticate for future patients, it may be a recipe for trouble.
Compare these developments with the analysis presented in Krzanowski’s paper (Krzanowski et
al. 1995) (for example ) on classification in the related setting of discrimination with near infrared
spectroscopic data. The analysis carried out there is actually rather cautious and conservative in
comparison and does not require the amount of pre-processing typically presented in proteomics papers.
Nevertheless, Krzanowski is able to demonstrate presence of an optimistic bias of 10% in the calculated
recognition rates for one of his classifiers - even though leave-one-out cross-validation is applied, as a
result of the tuning of only two (!) model parameters based on the full data (and with a sample size
considerable larger than for many current proteomics projects). In comparison, preprocessing efforts in
proteomics are typically near reckless with extensive preprocessing steps employed on the full data first,
following which ordinary leave-one-out calculations are frequently presented as if the first optimization
step had never taken place. To make matters worse, the classifiers employed are often highly complex
and new procedures which must yet pass the test of time and easily lead to overfitting (e.g. genetic
algorithms (Baggerly 2003)(Petricoin, et al. 2002) ). Good (and standard) statistical advice however,
will be to employ a conservative and inflexible class of predictors instead (e.g. Hand, page 153, or
McLachlan among others), based for example on first and second moments only.
The extent to which all this will induce optimistically biased assessments is hard to prejudge, but
there can be no doubt that the current state of affairs will sooner or later induce false-positive claims on
the abilities of mass spectrometry in specific research projects - if this has not yet materialized. Long
term, the impact on proteomic science itself may be disillusionment with proteomics and an averse
reaction, as overly optimistic claims due to improper analysis and study design do not materialize.
A more conservative approach and more stringent emphasis on full validation in the first stages of
evaluation can help to counteract this, as well as free valuable time and resources to those projects
that are truly worthy of further attention. In other words, the whole argument for proper validation
and cautious calibration does not restrict itself to what is ‘proper’ from a purely statistical point of
view - but also to the economics, viability and credibility of (proteomic) research and thus to research
planning. In this respect, good statistics leads to good scientific practice.
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5.2 Preprocessing, in particular alignment and feature ‘definition’
We want to discuss spectral ‘alignment’ and peak selection in more detail, as they pose special problems
when applied in any pre-processing of mass spectra that the analyst should be aware of, irrespective of
the precise methods employed.
Peak ‘selection’ (or discovery as some authors would phrase it) is really as much peak ‘definition’ as
anything else. From a practical point of view, the separation of the construction of the classifier into
two phases, the first of which identifies and aligns the ‘peaks’ may be useful. However, statistical science
has always regarded the distinction as artificial and more in tune with the pattern recognition literature
(Hand 1997)(page 51). Feature extraction and the construction of the classifier both form part of the
optimization of a diagnostic allocation rule. For that reason, proposals such as by Morris et al. to base
peak identification on the full data (by means of the average spectrum) make sense. However as we have
already pointed out, it implies use of the full data and therefore contravenes (cross-)validatory logic.
Another potential problem is that the approach is dependent on the within-group sample sizes, which
may cause difficulties with unbalanced designs. In principle, cross-validation can be applied to account
for peak-selection as well, but this would likely be a very costly procedure from a computational point of
view. The other option is to develop new classification methods which have some form of peak discovery
built into the classifier in such a way that it allows for efficient (cross-)validation (and for both choice
and assessment). If all else fails, use of separate tuning and validation sets is our only alternative, but
as we have discussed this will often be undesirable in the first instance due to the sampling costs (see
also further on for further comments on this issue). Even if we were to attempt to bypass the whole
issue by insisting that our only purpose is discovery of new ‘markers’ (proteins or peptides), some form
of validation will be of the essence in the construction of the discriminant models employed as a means
to protect against overfitting.
Alignment is a more tricky problem than peak discovery as it involves, by definition, reference to
other (calibration) samples. Hence, if cross-validatory analysis is employed within the same data to
either calibrate or validate the classification rule, bias will be implied by the referencing which has been
induced through aligning previously. At first sight, this might of course be taken as an argument to avoid
cross-validatory evaluation all together and insist on collecting additional sample material for separate
tuning and test sets. However, (besides the increased costs this will imply) we can not really escape
the problems posed by alignment within classification studies as the issue will return with a vengeance
as soon as we must allocate a new sample: with respect to which group do we align the new sample
for which diagnosis is required? Perhaps, this could be taken as an argument for employing so-called
‘nearest-neighbour type’ classifiers (try alignment of the new sample with - possibly a few samples from
- each group separately). However, these rules are notoriously unstable in high-dimensional problems.
Furthermore, the alignment problem exists already within the calibration set itself and leads to strange
dilemma’s: aligning spectra from one group with those from another reduces between-group separation
(makes them more alike) and does not seem the right course of action in the discriminant setting. The
opposite choice is equally unappealing as to align spectra within-group only is sure to induce an artificial
between-group separation.
From a statistical inferential point of view, the whole issue is therefore more difficult than appears
at first sight. While a proper treatment of the problem on statistical grounds is lacking (assuming this
is possible at all), it might be advisable not to align and - in the meantime - place some emphasis on
maintaining good laboratory practice and protocols instead. The only ‘error’ such choice implies is to
make our analyses more conservative only.
5.3 Double validatory analysis
As in our experiment, use of a separate validation set is often precluded in high dimensional problems,
due to sample size restrictions. Likewise, the need for predictive optimization and protection against
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overfitting may be addressed through use of an additional tuning set, but this greatly increases the
burden of collecting sufficient sample material in practice - often to the point of rendering the whole
endeavour impossible.
For such reasons, predictive optimization is usually carried out on the full data instead, which
results in optimistically biased error rate evaluations, particularly with high-dimensional data such as
in mass spectrometry proteomics. The other option is to reduce the available calibration data prior to
optimization so as to set aside data (perhaps for both a ‘predictive tuning’ as well as ‘validation’ set) but
this approach is not as innocuous as appears at first sight as it will often reduce the calibration set beyond
what is needed for reasonable calibration. More generally still, reducing the size of the calibration data
changes the condition of the estimation itself. To put this simply: we are not only reducing the data
by setting-aside aside data from the calibration set, but also changing the discriminant problem itself.
This is again particularly the case in high-dimensional cases such as in proteomics where the problem
will typically be ill-conditioned.
The approach we have described in this paper avoids these above discussed difficulties and dilemmas
by reducing the pre-processing to such an extent that it no longer induces the biases discussed and then
focuses on application of validation for both model calibration and evaluation through double cross-
validation. Subsequently, a more exploratory analysis can be carried out, provided we are carefully
to interpret results cautiously without contradicting the primary validated evaluation. We discuss a
number of issues related to application of (double) cross-validation.
5.3.1 Full validation
One potential cause for concern is whether double cross-validation precludes the need for a completely
separate validation set entirely. Is ‘double-cross’ also ‘full’ validation?
The answer to this question will of course depend on what we mean by ‘full validation’. Double cross-
validation should give reasonable protection against overfitting and unbiased estimates of error rate at
the time of study. Typically however, the performance of any decision rule or classifier has a tendency to
‘decay’ over time. To assess this, subsequent experiments are needed to verify the estimated error rates.
More generally, good scientific practice requires that we replicate results in a separate repeat study. This
is because cross-validation must ultimately always remain ‘within-study’ validation and there can be
factors beyond our knowledge which have influenced the study results. Note however that this applies
particularly to the definition of the case and control group, as the impact of systematic effects due to
measurement can be minimized through use of randomized block design. Repeat studies may help to
detect such problems. In this sense, double-cross represents the maximum usage we can make of the
data for joint calibration and validation within a single experiment in order to facilitate decision making
for further follow-up confirmatory experimentation. It is desirable to have such information available
as early as possible, as subsequent experimentation may be expensive and time consuming. See also
(Ransohoff 2004) for more discussion on these aspects.
5.3.2 What classifier are we evaluating?
Two related questions to the previous discussion are ‘What classifier does double cross-validation eval-
uate?’ and ‘How to assign a new observation?’. Indeed, each observation has its own classifier in the
double cross-validatory evaluation. This seems to run counter to the intuition that we calibrate a dis-
criminant rule first and only then evaluate. In that case, the estimated error rate is taken as a reflection
of the diagnostic abilities of that particular classifier and the allocation of a new sample is immediate.
There is however no logical inconsistency here. Double cross-validation estimates the error rate we
would get ‘if we were to apply leave-one-out’ on the whole data. Once we know what the error rate
is, we may choose the specific classifier (choice of k or λ in our case) for allocation of future samples
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(if required) through application of ordinary leave-one-out on the whole data (this is in line with the
discussion presented by Mervin Stone (Stone 1974)).
With double cross-validation, there are however other options to allow allocation of new samples
which have not yet been discussed in the literature. In our case for example, we may use the mode of
the number of components selected (k) across all samples and then re-estimate the discriminant model
with this choice from the full data. More adventurous still, we could retain each of the n classification
rules which are calibrated within the double-cross procedure and use this ensemble (of classifiers) for
allocation of any future new observation x. This could be done by calculating the associated a-posteriori
class probabilities pi(g | x), for each i ∈ {1, ..., n} and g ∈ {1, ..., G}, where pi is obtained from the
discriminant model calibrated in the double-cross procedure when the ith datum has been removed
from the data (in the outer shell of the double-cross procedure). Classification may then be based on
the mean across these n a-posteriori class probabilities for any gth class. We will not pursue these
options further in this paper.
5.4 Validation and the future of (statistical) proteomics
Rigorous emphasis on validation and proper design can help to establish long-term credibility for pro-
teomic research and more general bioinformatics applications. The double-cross approach with random-
ized block design described in this paper represents one contribution towards this goal. Many other
steps may however be taken to enhance the quality of such research studies. One example is to promote
use of ‘truly’ separate validation sets, as obtained from subsequent separate and additional sampling
from the population of interest and measurement through identical protocols as applied in the first
study. Of course, in practice, this will only be relevant for those studies which indicate potential from
the first within-study verification of diagnostic ability.
It would be desirable to stimulate greater awareness within the discipline on the requirements and
restrictions which validation imposes on any analysis. However, validation and the need for it, does not
only pose a test on the data or any model constructed from or for it. It does (or should) as much lead
to verification and restriction on the methodological soundness of any proposed data analysis procedure
itself. In this respect we have made reference to the considerable problems caused by pre-selection
and similarly, so-called alignment methods. The difficulty to gracefully combine such ad hoc approaches
with proper validation may well indicate a more fundamental problem with the data-analytic procedures
which are used. As a rule of thumb we should promote forms of analysis which may be validated. This
also implies feasibility of the validation schemes proposed. Of course, validation is in principle still
possible for pre-selection or construction of markers in principle at least through use of a separate
testing set, but this is not so evident for alignment procedures. In this paper, we have taken the view
that any methodology should be chosen to err on the conservative side, whenever such problems arise.
Editors of scientific journals can also contribute much to inspire such conservative attitude by careful
scrutiny of the papers presented for publication. Perhaps simple check lists could be developed to
prevent the major mistakes from slipping through the net. This may lead to considerable annoyance
in some cases when we face the difficulties of establishing results in the short term, but may enhance
scientific credibility of the science as a whole in the long run. Results from the present study show that,
with good designed experimentation, these precautions need not form unsurmountable obstacles.
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